Net Good IndexSubmit a correction

Benefit Ledger · provisional · Medicine & Health

Anthropic and Novo Nordisk expand Claude work, including in drug discovery - R&D World

Anthropic and Novo Nordisk expand Claude work, including in drug discovery  R&D World

Tier 1 UsefulMethodology 0.2
Submit a correction

Current score

+0.02

1 base · Useful (tier 1 of 5, 1 pts)
× 0.7500 attribution · Critical contribution
× 0.1500 evidence · Developer announcement
× 0.4000 realization · Demonstrated
× 0.5000 durability · Medium-term
Event-level product before credit split: 0.02

Ingest update: raised attribution; raised evidence; raised realization. Score remains provisional until review.

What happened

Anthropic and Novo Nordisk expand Claude work, including in drug discovery  R&D World Update (2026-09-16): Anthropic and Novo Nordisk expand Claude work, including in drug discovery - R&D World. Anthropic and Novo Nordisk expand Claude work, including in drug discovery  R&D World

Model attribution

Unspecified AI system
Version unspecified
+0.02

Unspecified

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.7500 · Credit share 100% · Unknown

Claims

  • Anthropic and Novo Nordisk expand Claude work, including in drug discovery - R&D World

    outcome · supported

Sources

primary sources

Revision history

  • 17 Sep 2026 · 0.00 → 0.00

    Auto-published from news ingest.

  • 17 Sep 2026 · 0.00 → 0.02

    Ingest update: raised attribution; raised evidence; raised realization.